162 related articles for article (PubMed ID: 35504549)
1. Risk factors for surgical failure in patients undergoing surgery for primary hyperparathyroidism.
Olguín Joseau S; Arias A; Garzón A; Peretti E; Guzmán L; Ruggieri M
Cir Esp (Engl Ed); 2022 Sep; 100(9):569-572. PubMed ID: 35504549
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for surgical failure in patients undergoing surgery for primary hyperparathyroidism.
Olguín Joseau S; Arias A; Garzón A; Peretti E; Guzmán L; Ruggieri M
Cir Esp (Engl Ed); 2021 Jul; ():. PubMed ID: 34253342
[TBL] [Abstract][Full Text] [Related]
3. Double adenoma as a cause of primary hyperparathyroidism: Asymmetric hyperplasia or a distinct pathologic entity?
Goodsell KE; Ermer JP; Zaheer S; Kelz RR; Fraker DL; Wachtel H
Am J Surg; 2021 Sep; 222(3):483-489. PubMed ID: 33551118
[TBL] [Abstract][Full Text] [Related]
4. [Primary hyperparathyroidism. Postoperative normocalcemic hyperparathyrinemia after curative parathyroidectomy].
Hermann M
Chirurg; 2010 May; 81(5):447-53. PubMed ID: 19468699
[TBL] [Abstract][Full Text] [Related]
5. Surgical approach and outcomes in patients with lithium-associated hyperparathyroidism.
Marti JL; Yang CS; Carling T; Roman SA; Sosa JA; Donovan P; Guoth MS; Heller KS; Udelsman R
Ann Surg Oncol; 2012 Oct; 19(11):3465-71. PubMed ID: 22669448
[TBL] [Abstract][Full Text] [Related]
6. Early biochemical response to parathyroidectomy for primary hyperparathyroidism and its predictive value for recurrent hypercalcemia and recurrent primary hyperparathyroidism.
Ryder CY; Jarocki A; McNeely MM; Currey E; Miller BS; Cohen MS; Gauger PG; Hughes DT
Surgery; 2021 Jan; 169(1):120-125. PubMed ID: 32768241
[TBL] [Abstract][Full Text] [Related]
7. Hyperparathyroidism during pregnancy. Is it a diagnostic and therapeutic challenge?
Godínez-Vidal AR; Oca-Durán ÉM; Aguirre-Rojano VI; Pulido-Cejudo A; Paul-Basurto-Kuba EO; Hurtado-López LM
Cir Cir; 2019; 87(S1):62-67. PubMed ID: 31501633
[TBL] [Abstract][Full Text] [Related]
8. Lithium-associated primary hyperparathyroidism:: An evaluation of screening and referral patterns in a southeastern veteran population.
Hendrick LE; Fleming AM; Sullivan JW; Usdan LS; Childress RD; Oktaei H; Kode SR; Dickson PV; DeLozier OM
Surgery; 2024 Jan; 175(1):187-192. PubMed ID: 37925259
[TBL] [Abstract][Full Text] [Related]
9. [Surgical treatment of hyperparathyroidism].
Târcoveanu E; Niculescu D; Moldovanu R; Cotea E; Vasilescu A; Dănilă N; Lăzescu D; Ferariu D; Crumpei F; Ichim M; Zbranca E
Chirurgia (Bucur); 2009; 104(5):531-44. PubMed ID: 19943551
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma.
Kandil E; Alabbas HH; Bansal A; Islam T; Tufaro AP; Tufano RP
Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1206-8. PubMed ID: 20026817
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid tissue in normocalcemic and hypercalcemic primary hyperparathyroidism recruited by health screening.
Lundgren E; Ridefelt P; Akerström G; Ljunghall S; Rastad J
World J Surg; 1996 Sep; 20(7):727-34; discussion 735. PubMed ID: 8678973
[TBL] [Abstract][Full Text] [Related]
12. Normocalcemic hyperparathyroidism: Intervention to differentiate primary from secondary hyperparathyroidism.
Baugh KA; McCoy KL; Leung JH; Carty SE; Ramonell KM; Yip L
Surgery; 2024 Jan; 175(1):166-171. PubMed ID: 37981554
[TBL] [Abstract][Full Text] [Related]
13. Update on the current management of persistent and recurrent primary hyperparathyroidism after parathyroidectomy.
Pavlidis ET; Pavlidis TE
World J Clin Cases; 2023 Apr; 11(10):2213-2225. PubMed ID: 37122518
[TBL] [Abstract][Full Text] [Related]
14. Eucalcemic parathyroid hormone elevation after parathyroidectomy for primary sporadic hyperparathyroidism: risk factors, trend, and outcome.
Lang BH; Wong IY; Wong KP; Lo CY
Ann Surg Oncol; 2012 Feb; 19(2):584-90. PubMed ID: 21732144
[TBL] [Abstract][Full Text] [Related]
15. Normocalcemic hyperparathyroidism after successful parathyroidectomy for single parathyroid adenoma: Prevalence, etiological factors, predictive markers, treatment and evolution.
García Pascual L; Simó-Servat A; Puig-Jové C; García-González L
Endocrinol Diabetes Nutr (Engl Ed); 2023 Dec; 70(10):640-648. PubMed ID: 38000970
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with late recurrence after parathyroidectomy for primary hyperparathyroidism.
Mallick R; Nicholson KJ; Yip L; Carty SE; McCoy KL
Surgery; 2020 Jan; 167(1):160-165. PubMed ID: 31606193
[TBL] [Abstract][Full Text] [Related]
17. Primary hyperparathyroidism.
Muñoz-Torres M; García-Martín A
Med Clin (Barc); 2018 Mar; 150(6):226-232. PubMed ID: 28992983
[TBL] [Abstract][Full Text] [Related]
18. Primary hyperparathyroidism in familial multiple endocrine neoplasia type I. Long-term follow-up of serum calcium levels after parathyroidectomy.
Rizzoli R; Green J; Marx SJ
Am J Med; 1985 Mar; 78(3):467-74. PubMed ID: 2858157
[TBL] [Abstract][Full Text] [Related]
19. Recurrence after successful parathyroidectomy-Who should we worry about?
Shirali AS; Wu SY; Chiang YJ; Graham PH; Grubbs EG; Lee JE; Perrier ND; Fisher SB
Surgery; 2022 Jan; 171(1):40-46. PubMed ID: 34340820
[TBL] [Abstract][Full Text] [Related]
20. Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level.
Gurrado A; Marzullo A; Lissidini G; Lippolis A; Rubini D; Lastilla G; Testini M
World J Surg Oncol; 2008 Feb; 6():24. PubMed ID: 18291038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
